IP Library Assignment 062343/0471
Patent Assignment
Reel/Frame 062343/0471

Assignment of Assignor's Interest

Recorded: 2023-01-11 Pages: 4
Assignor
LARPENT, PATRICK
Executed: 2022-08-18
Assignee
WERTHENSTEIN BIOPHARMA GMBH
INDUSTRIE NORD 1, SCHACHEN, 6105, SWITZERLAND
Covered Property (1)
Novel Synthetic Pathway to Belzutifan and Crystalline Phases of Synthetic Intermediates
Application: 17/749,452 →
Publication: US 2022/0388974
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 11, 2023
From: SHULTZ, CLINTON SCOTT; DALBY, STEPHEN M.; LEE, JOSHUA; CHEN, ZHIWEI
To: MERCK SHARP & DOHME CORP.
Reel/Frame 062342/0882 →
Assignment of Assignor's Interest Jan 11, 2023
From: DESAI, CHINTAL; PATEL, HET
To: MERCK SHARP & DOHME CORP.
Reel/Frame 062343/0047 →
Merger Jan 11, 2023
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 062343/0150 →
Assignment of Assignor's Interest Jan 11, 2023
From: GUO, HAIHENG; WANG, XIN; DAI, KANGZE; CHEN, LU
To: WUXI APPTEC (SHANGHAI) CO., LTD.
Reel/Frame 062343/0563 →
Nunc Pro Tunc Assignment Jan 11, 2023
From: WUXI APPTEC (SHANGHAI) CO., LTD.
To: MERCK SHARP & DOHME LLC
Reel/Frame 062343/0833 →